RE-DUAL PCI – In Review

PART 1: RE-DUAL PCI – Switching of NOACs after PCI in patients with atrial fibrillation

Educational objectives

  • Understand the latest data in relation to the NOACs and its implication on selected subgroups of populations.
  • Interpret the new data on the treatment of patients with atrial fibrillation and when to apply dual vs triple therapy treatment.
  • Understand the implementation of the emerging data and which patient groups should be treated differently.
Jur ten Berg
Department of Cardiology, St Antonius Ziekenhuis

 


Programme Outline
  • PART 1: RE-DUAL PCI – Switching of NOACs after PCI in patients with atrial fibrillationJur ten Berg
  • PART 2: RE-DUAL PCI – Diabetes sub-group analysisChristopher P Cannon
This video series was funded by an unrestricted educational service from Boehringer Ingelheim.

PART 2: RE-DUAL PCI – Diabetes sub-group analysis